Prof Kenneth Anderson speaks to ecancer.tv about the substantial advances that have been made in the availability of haemato-oncological treatments.

Prof Anderson also outlines promising new research looking at the inhibition of proteasomes and aggresomes and discusses the importance of the patient microenvironment, the role this plays in cancer progression and the way that this can be targeted to improve treatment.